Abenaa A Jones1, Kristin E Schneider2, Sherri-Chanelle Brighthaupt3, Julie K Johnson4, Sabriya L Linton5, Renee M Johnson6. 1. Department of Mental Health, Bloomberg School of Public Health, John Hopkins University, Baltimore, MD 21205, USA; Department of Health, Behavior, and Society, Bloomberg School of Public Health, John Hopkins University, Baltimore, MD 21205, USA. Electronic address: aacheam1@jhu.edu. 2. Department of Mental Health, Bloomberg School of Public Health, John Hopkins University, Baltimore, MD 21205, USA. Electronic address: kschne18@jhmi.edu. 3. Department of Mental Health, Bloomberg School of Public Health, John Hopkins University, Baltimore, MD 21205, USA. Electronic address: sbright5@jhu.edu. 4. Department of Mental Health, Bloomberg School of Public Health, John Hopkins University, Baltimore, MD 21205, USA; Commonwealth of Massachusetts, Cannabis Control Commission, Boston, MA 02110, USA. Electronic address: juliekatherinejohnson2@gmail.com. 5. Department of Mental Health, Bloomberg School of Public Health, John Hopkins University, Baltimore, MD 21205, USA. Electronic address: slinton1@jhu.edu. 6. Department of Mental Health, Bloomberg School of Public Health, John Hopkins University, Baltimore, MD 21205, USA. Electronic address: rjohnson@jhu.edu.
Abstract
BACKGROUND: Research on adolescent heroin use has focused on national surveillance, access, prevalence of use, and overdose deaths, however, to our knowledge, no study has examined local-level differences in the prevalence of adolescent heroin use in the context of nonmedical prescription opioid (NMPO) use. This study characterizes heroin and NMPO use among US high school students in select urban areas by sex and race/ethnicity. METHODS: Data are from 21 urban school districts that participate in CDC's Local Youth Risk Behavior Surveillance System. We describe 2017 prevalence estimates (and 95 % confidence intervals) of lifetime heroin and NMPO use among youth stratified by sex and race/ethnicity (i.e., White, Black, Hispanic/Latino). RESULTS: The highest estimates of heroin use were in Baltimore, MD (7.6 %), Shelby County, TN (6.3 %), and Duval County, FL (6.1 %), whereas NMPO use was highest in Duval County, FL (18.1 %), Cleveland, OH (18.0 %), and Shelby County, TN (16.8 %). Heroin use was higher among boys than girls, especially among Hispanic/Latino boys in Duval County (12.3 %) and Black boys in Baltimore (10.9 %). NMPO use was highest among Hispanic/Latino girls (21.3 %) and White girls (19.9 %) in Duval County. DISCUSSION: While some cities and subpopulations with high levels of adolescent heroin use also had elevated levels of NMPO use, others did not, illustrating the complexities of this opioid epidemic.
BACKGROUND: Research on adolescent heroin use has focused on national surveillance, access, prevalence of use, and overdose deaths, however, to our knowledge, no study has examined local-level differences in the prevalence of adolescent heroin use in the context of nonmedical prescription opioid (NMPO) use. This study characterizes heroin and NMPO use among US high school students in select urban areas by sex and race/ethnicity. METHODS: Data are from 21 urban school districts that participate in CDC's Local Youth Risk Behavior Surveillance System. We describe 2017 prevalence estimates (and 95 % confidence intervals) of lifetime heroin and NMPO use among youth stratified by sex and race/ethnicity (i.e., White, Black, Hispanic/Latino). RESULTS: The highest estimates of heroin use were in Baltimore, MD (7.6 %), Shelby County, TN (6.3 %), and Duval County, FL (6.1 %), whereas NMPO use was highest in Duval County, FL (18.1 %), Cleveland, OH (18.0 %), and Shelby County, TN (16.8 %). Heroin use was higher among boys than girls, especially among Hispanic/Latino boys in Duval County (12.3 %) and Black boys in Baltimore (10.9 %). NMPO use was highest among Hispanic/Latino girls (21.3 %) and White girls (19.9 %) in Duval County. DISCUSSION: While some cities and subpopulations with high levels of adolescent heroin use also had elevated levels of NMPO use, others did not, illustrating the complexities of this opioid epidemic.
Authors: Magdalena Cerdá; Julián Santaella; Brandon D L Marshall; June H Kim; Silvia S Martins Journal: J Pediatr Date: 2015-06-06 Impact factor: 4.406
Authors: Sean Esteban McCabe; Brady T West; Phil Veliz; Vita V McCabe; Sarah A Stoddard; Carol J Boyd Journal: Pediatrics Date: 2017-03-20 Impact factor: 7.124
Authors: Sherri-Chanelle Brighthaupt; Kristin E Schneider; Julie K Johnson; Abenaa A Jones; Renee M Johnson Journal: J Adolesc Health Date: 2019-08 Impact factor: 5.012
Authors: Lorraine I Kelley-Quon; Junhan Cho; David R Strong; Richard A Miech; Jessica L Barrington-Trimis; Afton Kechter; Adam M Leventhal Journal: JAMA Pediatr Date: 2019-09-02 Impact factor: 16.193
Authors: Elizabeth J D'Amico; Jordan P Davis; Joan S Tucker; Rachana Seelam; Bradley D Stein Journal: Addict Behav Date: 2020-10-07 Impact factor: 3.913
Authors: Sasha Deutsch-Link; Annabelle M Belcher; Ebonie Massey; Thomas O Cole; Michael A Wagner; Amy S Billing; Aaron D Greenblatt; Eric Weintraub; Eric D Wish Journal: J Ethn Subst Abuse Date: 2021-02-07 Impact factor: 1.331
Authors: Sabriya L Linton; Abigail Winiker; Kayla N Tormohlen; Kristin E Schneider; Grace McLain; Susan G Sherman; Renee M Johnson Journal: Prev Sci Date: 2021-04-07